IAIM
CATX icon

International Assets Investment Management’s Perspective Therapeutics CATX Stock Holding History

International Assets Investment Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311 Hold
90
– – ﹤0.01% 2296
2026
Q1 		$398 Hold
90
– – ﹤0.01% 2148
2025
Q4 		$248 Buy
+90
New +$257 ﹤0.01% 2151
2024
Q4 		– Sell
-1,202
Closed -$90 – 982
2024
Q3 		$90 Buy
1,202
+1,112
+1,236% +$14.8K ﹤0.01% 1663
2024
Q2 		$897 Buy
+90
New +$1.3K ﹤0.01% 2112
2021
Q2 		– Sell
-90
Closed – – 704
2021
Q1 		$0 Hold
90
– – ﹤0.01% 2180
2020
Q4 		$0 Buy
+90
New +$398 ﹤0.01% 2078

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $170M AUM 10.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.35B AUM 17.18% 1-Year Est. Return
WIM
WealthPlan Investment Management Omaha, Nebraska $2.01B AUM 27.28% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

International Assets Investment Management's CATX Position: Q2 2026 in Review

International Assets Investment Management held its Perspective Therapeutics (CATX) position steady in Q2 2026 at 90 shares worth $311. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

International Assets Investment Management first reported a position in CATX in Q4 2020 and has held it in 7 quarters since. The position peaked at $897 in Q2 2024. 68 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • International Assets Investment Management held 90 shares of Perspective Therapeutics worth $311 as of Q2 2026.
  • International Assets Investment Management left its Perspective Therapeutics share count unchanged in Q2 2026.
  • Perspective Therapeutics made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2296 holding.
  • International Assets Investment Management first reported a position in Perspective Therapeutics in Q4 2020 and has held it in 7 quarters since.
  • International Assets Investment Management's Perspective Therapeutics position peaked at $897 in Q2 2024.
  • 68 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.